Unknown

Dataset Information

0

RB Loss Promotes Prostate Cancer Metastasis.

ABSTRACT: RB loss occurs commonly in neoplasia but its contributions to advanced cancer have not been assessed directly. Here we show that RB loss in multiple murine models of cancer produces a prometastatic phenotype. Gene expression analyses showed that regulation of the cell motility receptor RHAMM by the RB/E2F pathway was critical for epithelial-mesenchymal transition, motility, and invasion by cancer cells. Genetic modulation or pharmacologic inhibition of RHAMM activity was sufficient and necessary for metastatic phenotypes induced by RB loss in prostate cancer. Mechanistic studies in this setting established that RHAMM stabilized F-actin polymerization by controlling ROCK signaling. Collectively, our findings show how RB loss drives metastatic capacity and highlight RHAMM as a candidate therapeutic target for treating advanced prostate cancer. Cancer Res; 77(4); 982-95. ©2016 AACR.

SUBMITTER: Thangavel C 

PROVIDER: S-EPMC5700768 | biostudies-literature | 2017 Feb

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

RB loss occurs commonly in neoplasia but its contributions to advanced cancer have not been assessed directly. Here we show that RB loss in multiple murine models of cancer produces a prometastatic phenotype. Gene expression analyses showed that regulation of the cell motility receptor RHAMM by the RB/E2F pathway was critical for epithelial-mesenchymal transition, motility, and invasion by cancer cells. Genetic modulation or pharmacologic inhibition of RHAMM activity was sufficient and necessary  ...[more]

Similar Datasets

Unknown Loss of miR-449a-caused PrLZ overexpression promotes prostate cancer metastasis.
| S-EPMC5504971 | biostudies-other
Unknown Activation of Rap1 promotes prostate cancer metastasis.
| S-EPMC4195850 | biostudies-other
Unknown Endothelial Akt1 loss promotes prostate cancer metastasis via β-catenin-regulated tight-junction protein turnover.
| S-EPMC5988746 | biostudies-literature
Unknown CHD1 loss negatively influences metastasis-free survival in R0-resected prostate cancer patients and promotes spontaneous metastasis in vivo.
| S-EPMC8761572 | biostudies-literature
Unknown Loss of EGFR signaling regulated miR-203 promotes prostate cancer bone metastasis and tyrosine kinase inhibitors resistance.
| S-EPMC4116519 | biostudies-other
Unknown NUSAP1 promotes invasion and metastasis of prostate cancer.
| S-EPMC5444715 | biostudies-literature
Unknown Prostate-specific loss of UXT promotes cancer progression.
| S-EPMC6366831 | biostudies-literature
Unknown Integrin alpha2beta 1 (α2β1) promotes prostate cancer skeletal metastasis.
| S-EPMC3736758 | biostudies-literature
Unknown FABP5 coordinates lipid signaling that promotes prostate cancer metastasis.
| S-EPMC6908725 | biostudies-literature
Unknown EphA6 promotes angiogenesis and prostate cancer metastasis and is associated with human prostate cancer progression.
| S-EPMC4673184 | biostudies-literature